Photo: Closeup of microscope

Siponimod

Siponimod (also known as BAF312) is a tablet being developed for secondary progressive MS by Novartis Pharmaceuticals.

Current phase of trial: Phase 3

Type of MS: Secondary progressive MS

About siponimod